Cargando…
TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p
BACKGROUND: The role of TMED3 involved in cancers has been seldom described, let alone in breast cancer. To explore the clinicopathological significance of TMED3 expression and the biological roles involved in breast cancer cells, we undertook the study. METHODS: Immunohistochemistry was performed t...
Autores principales: | Pei, Jing, Zhang, Jing, Yang, Xiaowei, Wu, Zhengsheng, Sun, Chenyun, Wang, Zhaorui, Wang, Benzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441222/ https://www.ncbi.nlm.nih.gov/pubmed/30976199 http://dx.doi.org/10.1186/s12935-019-0791-4 |
Ejemplares similares
-
Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022) -
TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
por: Xu, Wei, et al.
Publicado: (2021) -
Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis
por: Chen, Fei-Yu, et al.
Publicado: (2020) -
MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3
por: Wang, Yong-Xia, et al.
Publicado: (2018) -
The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020)